ArticleScience, technology & human values2026
What's in the Blood? Temporalities at Play in Diet-Related Risk Management Testing Practices.
Article in Science, technology & human values, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, I look at two different sets of practices that are part of the risk management apparatus in place in Québec & Canada to apprehend and control risks associated with food consumption. More specifically, I contrast diabetes and chemical contaminants risk management testing practices, so as to compare how both frame and approach risks, in a context where recent research in social sciences, epigenetics and environmental sciences increasingly points to "environmental" pathways of disease causation while many chronic conditions remain highly individualized in public and health discourses. The analysis pays close attention to the different temporalities discursively created, considered, and neglected in these practices in order to understand how risk is approached and worked on. This highlights the power relations that inform how we care (or not) for (certain) bodies, inflecting in particular ways their-uneven-becomings. I argue that the Canadian biotechnological apparatus of testing practices meant to apprehend and control diet-related risks contributes to foreclosing the temporalities of health and illness considered and acted upon. As such, the apparatus contributes to (re)producing inequalities, here mostly health related ones, as well as creating differentiated biological materialities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.